About Us
About Us
History
Commitment
Leadership Team
Awards and Recognition
Locations
Corporate Compliance
Historical Innovation
View our Interactive Timeline
Therapies
Therapies
Neurodegenerative Diseases
Fertility
Metabolic Endocrinology
Oncology
Patient Information
We Are Committed to our Patients
Clinical Trials
Research
Research
R&D Focus and Vision
Breakthrough Innovations
Scientist Profiles
Pipeline
Meet Our Scientists
Brian
Christel
Gene
Jamie
Regina
Vanita
Partnering
Partnering
What we are looking for
We are Committed to Success through Partnerships
Responsibility
Responsibility
Patient and Community Programs
Interacting with Healthcare Professionals & Organizations
Corporate Giving
Environmental Commitment
A Growing Community of Good Citizens
Read the PharmaVoice Article
Media
Media
Press Releases
Media Kit
Latest Press Releases
EMD Serono Expands Global Research & Development Hub in Massachusetts and Continues to Build Presence in US Pharmaceuticals Market
EMD Serono Announces Appeals Court Decision
EMD Serono: Phase III Trial of Cilengitide Did Not Meet Primary Endpoint in Patients With Newly Diagnosed Glioblastoma
EMD Serono and Pfizer Announce FDA Approval of Rebif® Rebidose® (interferon beta-1a)
Careers
Careers
I Made it Happen
Job Center
Meet our Employees
Culture
Benefits
Learn more about working at EMD Serono
Meet our Employees
Home
Sitemap
Contacts
Search
I Made it Happen
Job Center
Meet our Employees
Culture
Benefits
Home
Careers
I Made it Happen
I Made it Happen
noscript
